omas T

Behavioral Changes Following 4-Week Inhalation Exposure to Pseudocumene (1,2,4-Trimethylbenzene) in the Rat

Pseudocumene (1,2,4-trimethylbenzene, TMB) is a component of several solvent mixtures. During recent studies on rats we investigated the effect of a 4-week (6 h/day, 5 days/week) inhalation exposure to TMB at concentrations of 0, 25, 100, or 250 ppm on radial maze performance, open field activity, passive avoidance, active two-way avoidance, and shock-induced changes in the pain sensitivity reflecting the magnitude of the shock-induced fear response (hot plate test). The tests were performed between days 14 and 54 after the last exposure. The radial maze performance was not disturbed in any dose group. During testing in the open field grooming was significantly increased in rats exposed to 100 ppm TMB. In rats exposed to 100 and 250 ppm TNB, a foot shock applied after stepping off an elevated platform (a safe area) resulted in a significantly smaller increase in the step-down latency (i.e., passive avoidance, on days 3 and 7 after the foot shock) than in sham-exposed animals. Learning of a two-way active avoidance was slightly retarded in rats exposed to 250 ppm of TMB. Results of the hot plate test revealed no differences between groups in the paw sensitivity to heat (54.5 degrees C) before a 2-min intermittent food shock, but in rats exposed to 100 and 250 ppm of TMB the foot shock-induced fear response persisted apparently longer. These results suggest that inhalation exposure to TMB may lead to long-lasting disturbances in CNS functions.

Alteration in behavioral sensitivity to amphetamine after treatment with oxotremorine. Effect of dose and test environment.

Our earlier experiment revealed that rats pretreated once with an anticholinesterase develop hyposensitivity to amphetamine (AMPH). One of the likely causes of this effect might be a transient hyperexcitation of the central muscarinic receptors. It has appeared, however, that rats pretreated with oxotremorine (OX), a muscarinic agonist, show an augmented behavioral response to AMPH weeks later. The present experiments were performed in order to obtain more information on the relationship between the OX-induced sensitization to AMPH and the OX dose and dosing regime (single or repeated), and to find out whether the environment associated with the acute effects of OX could affect the response to AMPH. In experiment 1, adult male rats were given a single i.p. injection of OX in home cages at a moderate (0.5 mg/kg) or high (1.0 mg/kg) dose. In experiment 2, the rats received eight 1.0 mg/kg doses of OX in the course of three days. After each injection, some animals returned to their home cages, and some were placed in the test cages for 30 min. In both experiments, the response to AMPH was assessed on day 21 after the treatment. The obtained results indicate that: (i) a single i.p. exposure to OX results in an increase of the rats behavioral sensitivity to AMPH but the moderate dose is more effective in inducing this effect; (ii) repeated exposure to OX at high doses, in a regime enabling development of tolerance to the acute OX effects, does not alter the rat sensitivity to AMPH, and (iii) expression of the AMPH response is suppressed in environment which has been associated with acute effects of OX.

Interaction of chlorphenvinphos with cholinergic receptors in the rabbit hypothalamus

The purpose of this study was to find out whether chlorphenvinphos (CVP), an organophosphorous pesticide, interacts with the muscarinic cholinergic receptors in CNS. To attain this goal, the effects of intrahypothalamic injections of oxotremorine (Ox), a muscarinic agonist, and physostigmine (Phys), a carbamate anticholinesterase, were compared with those produced by intrahypothalamic injections of CVP in the rabbit. It was found that the infusion of Ox (20 micrograms) as well as Phys (200 micrograms) into the anterior hypothalamus leads to an increase in the 4-7 Hz theta rhythm in the hippocampus and to the appearance of behavioral symptoms suggestive of a threat response. In the case of Ox, the effects could be prevented by injections of 20 micrograms scopolamine, a muscarinic antagonist. Pretreatment of the hypothalamus with 100 micrograms hemicholinium (HC-3) did not prevent the effects of Phys injected 2 h later. (HC-3 prevents the resynthesis of acetylcholine by blocking choline reuptake. This leads to a gradual depletion of ACh stores and to an inhibition of the cholinergic transmission). It suggests that Phys activates directly postsynaptic muscarinic receptors. Intrahypothalamic injections of CVP in doses of up to 1360 micrograms produced no overt changes in behavior nor in the hippocampal EEG of the rabbit and did not prevent the effect of subsequent injections of Ox. This suggests that CVP is neither an agonist nor antagonist of the muscarinic receptors in the rabbit hypothalamus.